SNS Insider Unveils Strategic Insights into the U.S. ELISpot and Fluorospot Assay Market’s Rapid Growth—Valued at USD 79.68 Million in 2023—While the U.S. Commands Over 40% of the Global ...

The global ELISpot and FluoroSpot Assays market size is projected to reach USD 390 million by 2027 from USD 274 million in 2022, at a CAGR of 7.3% during the forecast period.

The Global Elispot and Fluorospot Assay Market is valued at USD 432 Million in 2024 and is projected to reach a value of USD 2155 Million by 2035 at a CAGR (Compound Annual Growth Rate) of 15.75% ...

ELISPOT assay revealed the frequent existence of insulin peptide-specific T cells in patients with recent ... Figure 2 shows the positive spots for each peptide in patients with recent-onset and ...

Kobe University and Sysmex Corporation have been engaged in joint research on the ELISPOT method, a new blood test for identifying COVID-19. This method makes it possible to detect the immune ...

Kobe University and Sysmex Corporation have been engaged in joint research on the ELISPOT method, a new blood test for identifying the novel coronavirus disease (COVID-19).

Background: P10-1 (NCT01338012) is a study of sipuleucel-T, an autologous cellular immunotherapy, in men with mCRPC previously treated with sipuleucel-T in PROTECT (NCT00779402). This preliminary ...

According to SNS Insider, the global ELISpot and Fluorospot Assay Market was valued at USD 290.92 million in 2023 and is projected to reach USD 528.30 million by 2032, growing at a CAGR of 6.85% ...

Elispot and Fluorospot Market Elispot and Fluorospot Market Dublin, Nov. 21, 2022 (GLOBE NEWSWIRE) -- The "ELISpot and FluoroSpot Assay Market by Product (Assay Kit (T Cell and B Cell assay), Analyzer ...